Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Rubenstein

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|April 12, 2017
Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapyNeel K Gupta, Chia-Ching Wang, Gabriel N Mannis, et al.
The American Journal of Pathology|February 20, 2021
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell LymphomaJustin P Chan, Mario Merlini, Hua-Xin Gao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS LymphomaAndreas Rauschecker, Michael Romano, Jinchi Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS LymphomaAndreas Rauschecker, Michael Romano, Jinchi Wei, et al.
AJR. American Journal of Roentgenology|October 27, 2015
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain NeoplasmsMarc C Mabray, Benjamin A Cohen, Javier E Villanueva-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2013
Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphomaCigall Kadoch, Jing Li, Valerie S Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)James L Rubenstein, Eric D Hsi, Jeffrey L Johnson, et al.
Blood Advances|November 13, 2024
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphomaHuimin Geng, Shirley Mo, Lingjing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphomaJames L Rubenstein, Jane Fridlyand, Lauren Abrey, et al.
Blood|October 24, 2002
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartmentJames L Rubenstein, Dan Combs, Jay Rosenberg, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|April 12, 2017
Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapyNeel K Gupta, Chia-Ching Wang, Gabriel N Mannis, et al.
The American Journal of Pathology|February 20, 2021
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell LymphomaJustin P Chan, Mario Merlini, Hua-Xin Gao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS LymphomaAndreas Rauschecker, Michael Romano, Jinchi Wei, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS LymphomaAndreas Rauschecker, Michael Romano, Jinchi Wei, et al.
AJR. American Journal of Roentgenology|October 27, 2015
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain NeoplasmsMarc C Mabray, Benjamin A Cohen, Javier E Villanueva-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2013
Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphomaCigall Kadoch, Jing Li, Valerie S Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)James L Rubenstein, Eric D Hsi, Jeffrey L Johnson, et al.
Blood Advances|November 13, 2024
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphomaHuimin Geng, Shirley Mo, Lingjing Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphomaJames L Rubenstein, Jane Fridlyand, Lauren Abrey, et al.
Blood|October 24, 2002
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartmentJames L Rubenstein, Dan Combs, Jay Rosenberg, et al.
Pageof 6